
Black Rose Indus Q1 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 4
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 4- Company expects positive growth in sales and volumes in the current year driven by improved market demand and price realizations.
- Focus on achieving about 10% profit margins typical for the year.
- Expansion plans with new capacity additions primarily in the subsequent year.
- Increased export volumes, especially in manufacturing division, supported by EU and Turkey REACH registrations, boosting exports and revenues.
- New orders for N-Methylol Acrylamide (NMA) from multinational and domestic customers expected to substantially increase volumes.
- Commercial launch of Polyacrylamide Solids targeted by Q3 FY25, expected to add to revenue streams.
- Despite challenges like Chinese dumping affecting domestic sales, exports and better price realizations should drive growth.
- Emphasis on maximizing revenues and profit over mere capacity utilization for new product lines.
- Overall good growth expected in both distribution and manufacturing divisions compared to previous periods.
See what Black Rose Indus management said on margin guidance — free account, 30 seconds.
Fundraise plans
- There is no mention of any current or planned fundraising through debt or equity in the transcript.
- The company maintains a strong financial position with a negligible Debt Equity Ratio of 0.01.
- Focus is on optimizing inventory and reducing sundry debtors to support future projects and business prospects.
- CapEx plans are mainly related to capacity expansion and technology development, but funding sources are not specified as new fundraising.
- No explicit discussion about raising funds through equity or additional debt during the call.
See what Black Rose Indus management said on order book — free account, 30 seconds.
Capex plans
YesTrack Black Rose Indus — get its next earnings analysis in your feed
How does Black Rose Indus rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Black Rose Indus rank in Chemicals & Petrochemicals?
Compare Black Rose Indus against every Chemicals & Petrochemicals company (Q1 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Black Rose Indus's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…